Literature DB >> 34694874

Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection.

Brianna M Eales1, Vincent H Tam1,2.   

Abstract

Acinetobacter baumannii is a pathogenic bacterium commonly associated with multidrug resistance. In this issue of Antimicrobial Agents and Chemotherapy, a challenging case of ventilator-associated pneumonia is presented in which bacteriophage therapy was used as a last resort treatment in combination with systemic antibiotics. The data are promising, and several key areas are highlighted for future research.

Entities:  

Keywords:  bacteriophage delivery; bacteriophage therapy; pneumonia; treatment; ventilator-associated pneumonia

Mesh：

Substances：

Year:  2021        PMID： 34694874      PMCID： PMC8765303          DOI： 10.1128/AAC.01996-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


  4 in total

1.  Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections.

Authors:  Katie A Parsels; Keri A Mastro; Jeffrey M Steele; Stephen J Thomas; Wesley D Kufel
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790

2.  Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.

Authors:  Sohail Rao; Monica Betancourt-Garcia; Yetunde O Kare-Opaneye; Brett E Swierczewski; Jason W Bennett; Bri'Anna Horne; Joseph Fackler; Lia Patricia Suazo Hernandez; Michael J Brownstein
Journal:  Antimicrob Agents Chemother       Date:  2021-10-18       Impact factor: 5.938

Review 3.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

4.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Authors:  Evelina Tacconelli; Elena Carrara; Alessia Savoldi; Stephan Harbarth; Marc Mendelson; Dominique L Monnet; Céline Pulcini; Gunnar Kahlmeter; Jan Kluytmans; Yehuda Carmeli; Marc Ouellette; Kevin Outterson; Jean Patel; Marco Cavaleri; Edward M Cox; Chris R Houchens; M Lindsay Grayson; Paul Hansen; Nalini Singh; Ursula Theuretzbacher; Nicola Magrini
Journal:  Lancet Infect Dis       Date:  2017-12-21       Impact factor: 71.421
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.